Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,059,092
+$223,143 QoQ
Shares Held
37,844
-11.6% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#265
of 754 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Utah Retirement Systems holds $63,005,640 across 24 Biotechnology names. EXEL ranks #8 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
38,602 | $19,174,771 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15,346 | $9,568,844 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
20,236 | $6,091,643 | |
| 4 | MRNA |
Moderna, Inc.
|
55,289 | $3,871,888 | |
| 5 | RPRX |
Royalty Pharma plc
|
62,812 | $3,521,868 | |
| 6 | INSM |
INSMED Inc
|
32,484 | $3,463,444 | |
| 7 | INCY |
Incyte Corp
|
25,159 | $2,852,024 | |
| 8 | EXEL |
Exelixis, Inc.
This page
|
37,844 | $2,059,092 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,059,092 | 37,844 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,835,949 | 42,806 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,907,350 | 43,517 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,797,252 | 43,517 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,012,428 | 45,654 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,714,306 | 46,433 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,577,187 | 47,363 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,229,069 | 47,363 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,064,246 | 47,363 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,271,049 | 53,563 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,320,961 | 55,063 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,205,311 | 55,163 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,046,520 | 54,763 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,086,241 | 55,963 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $891,230 | 55,563 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $871,227 | 55,563 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,148,493 | 55,163 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $1,250,545 | 55,163 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,026,659 | 56,163 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,183,057 | 55,963 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,076,127 | 59,063 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,331,974 | 58,963 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,233,562 | 61,463 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,424,530 | 58,263 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,373,667 | 57,863 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $979,180 | 56,863 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||